ICER Releases Report on Therapies for Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of [...]
ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
Alexion Pharmaceuticals Braces for Major Competitor
While Alexion Pharmaceuticals' blockbuster drug Soliris netted more than $3 billion for the company last year, the drug could face [...]
Advertisement
